Cell-intrinsic glial pathology is conserved across human and murine models of Huntington's disease
Research output: Contribution to journal › Journal article › Research › peer-review
Standard
Cell-intrinsic glial pathology is conserved across human and murine models of Huntington's disease. / Benraiss, Abdellatif; Mariani, John N.; Osipovitch, Mikhail; Cornwell, Adam; Windrem, Martha S.; Villanueva, Carlos Benitez; Chandler-Militello, Devin; Goldman, Steven A.
In: Cell Reports, Vol. 36, No. 1, 109308, 2021.Research output: Contribution to journal › Journal article › Research › peer-review
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Cell-intrinsic glial pathology is conserved across human and murine models of Huntington's disease
AU - Benraiss, Abdellatif
AU - Mariani, John N.
AU - Osipovitch, Mikhail
AU - Cornwell, Adam
AU - Windrem, Martha S.
AU - Villanueva, Carlos Benitez
AU - Chandler-Militello, Devin
AU - Goldman, Steven A.
PY - 2021
Y1 - 2021
N2 - Glial pathology is a causal contributor to the striatal neuronal dysfunction of Huntington's disease (HD). We investigate mutant HTT-associated changes in gene expression by mouse and human striatal astrocytes, as well as in mouse microglia, to identify commonalities in glial pathobiology across species and models. Mouse striatal astrocytes are fluorescence-activated cell sorted (FACS) from R6/2 and zQ175 mice, which respectively express exon1-only or full-length mHTT, and human astrocytes are generated either from human embryonic stem cells (hESCs) expressing full-length mHTT or from fetal striatal astrocytes transduced with exon1-only mHTT. Comparison of differential gene expression across these conditions, all with respect to normal HTT controls, reveals cell-type-specific changes in transcription common to both species, yet with differences that distinguish glia expressing truncated mHTT versus full-length mHTT. These data indicate that the differential gene expression of glia expressing truncated mHTT may differ from that of cells expressing full-length mHTT, while identifying a conserved set of dysregulated pathways in HD glia.
AB - Glial pathology is a causal contributor to the striatal neuronal dysfunction of Huntington's disease (HD). We investigate mutant HTT-associated changes in gene expression by mouse and human striatal astrocytes, as well as in mouse microglia, to identify commonalities in glial pathobiology across species and models. Mouse striatal astrocytes are fluorescence-activated cell sorted (FACS) from R6/2 and zQ175 mice, which respectively express exon1-only or full-length mHTT, and human astrocytes are generated either from human embryonic stem cells (hESCs) expressing full-length mHTT or from fetal striatal astrocytes transduced with exon1-only mHTT. Comparison of differential gene expression across these conditions, all with respect to normal HTT controls, reveals cell-type-specific changes in transcription common to both species, yet with differences that distinguish glia expressing truncated mHTT versus full-length mHTT. These data indicate that the differential gene expression of glia expressing truncated mHTT may differ from that of cells expressing full-length mHTT, while identifying a conserved set of dysregulated pathways in HD glia.
KW - MUTANT HUNTINGTIN
KW - GENE-EXPRESSION
KW - TRANSCRIPTIONAL PROFILES
KW - CHOLESTEROL-BIOSYNTHESIS
KW - DECREASED EXPRESSION
KW - PROGENITOR CELLS
KW - MOUSE MODEL
KW - CAG REPEAT
KW - MICROGLIA
KW - ASTROCYTES
U2 - 10.1016/j.celrep.2021.109308
DO - 10.1016/j.celrep.2021.109308
M3 - Journal article
C2 - 34233199
VL - 36
JO - Cell Reports
JF - Cell Reports
SN - 2211-1247
IS - 1
M1 - 109308
ER -
ID: 274270784